Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
TgTor icon

1.1 by Imagicahealth


May 6, 2019

About TgTor

TG-tor ASCVD risk calculator provides estimation of 10year and lifetime risk for

TG-tor ASCVD risk calculator provides estimation of 10-year and lifetime risk for

atherosclerotic cardiovascular disease using the Pooled Cohort Equations and lifetime risk

prediction tools. It calculates the 10-year primary risk of atherosclerotic cardiovascular disease

among patients without established cardiovascular disease who are between 40 and 79 years

of age. Estimation of 10-year risk for atherosclerotic cardiovascular disease are based on data

from multiple community-based populations and are applicable to African-American and non-

Hispanic white men and women 40 through 79 years of age.

TG-tor ASCVD risk calculator provides easy access to recommendations specific to the risk

estimates produced by the calculator. Additionally, the app includes readily accessible guideline

reference information for both providers and patients related to therapy, monitoring, and

lifestyle. Patients are considered to be at ‘elevated risk’ if the Pooled Cohort Equations predicted

risk is ≥ 7.5%.

What's New in the Latest Version 1.1

Last updated on May 6, 2019

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request TgTor Update 1.1

Uploaded by

Enzo Duarte

Requires Android

Android 2.2+

Show More

TgTor Screenshots

Comment Loading...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.